ASLAN Announces Publication of New Pre-Clinical Data Demonstrating the Activity of Varlitinib in TNBC Cell Lines
January 23, 2019 01:35 ET
|
ASLAN Pharmaceuticals Limited
SINGAPORE, Jan. 23, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and...
Insight Genetics Launches First-of-its-kind Test for Triple Negative Breast Cancer
December 03, 2018 09:36 ET
|
Insight Genetics
NASHVILLE, Tenn., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Insight Genetics, Inc. today announced the launch of its proprietary Insight TNBCtype™, a new test for categorizing triple negative breast cancer...
ERYTECH partecipa alle prossime conferenze degli investitori
September 13, 2018 17:30 ET
|
Erytech Pharma S.A.
LIONE, Francia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), una società biofarmaceutica di fase clinica che sviluppa terapie innovative incapsulando...
ERYTECH nimmt an kommenden Investorenkonferenzen teil
September 13, 2018 17:30 ET
|
Erytech Pharma S.A.
LYON, Frankreich, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), ein in der klinischen Entwicklungsphase tätiges Biopharma-Unternehmen, das innovative...
ERYTECH participera à plusieurs conférences d'investisseurs
September 13, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, 13 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant...
ERYTECH to Attend Upcoming Investor Conferences
September 13, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...
ERYTECH tiendra un webcast le 11 septembre 2018 à l’occasion de ses résultats semestriels 2018
September 06, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, 06 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant...
ERYTECH to Host Second Quarter 2018 Conference Call and Business Update
September 06, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, Sept. 06, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...
ERYTECH to Webcast Presentation at the Jefferies Global Healthcare Conference
May 30, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, May 30, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...
ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update
May 14, 2018 16:30 ET
|
Erytech Pharma S.A.
Finalized Phase 3 trial design for eryaspase in second line pancreatic cancer; on track for expected start of patient enrollment in Q3Selected triple-negative breast cancer as the next solid tumor...